Compare MRNA & OC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MRNA | OC |
|---|---|---|
| Founded | 2010 | 1938 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.3B | 9.3B |
| IPO Year | 2018 | N/A |
| Metric | MRNA | OC |
|---|---|---|
| Price | $25.14 | $114.09 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 13 | 13 |
| Target Price | $33.91 | ★ $160.33 |
| AVG Volume (30 Days) | ★ 10.0M | 2.2M |
| Earning Date | 11-06-2025 | 11-05-2025 |
| Dividend Yield | N/A | ★ 2.42% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $2,232,000,000.00 | ★ $11,659,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $0.77 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 21.69 |
| 52 Week Low | $22.28 | $97.53 |
| 52 Week High | $48.92 | $205.75 |
| Indicator | MRNA | OC |
|---|---|---|
| Relative Strength Index (RSI) | 50.59 | 53.46 |
| Support Level | $23.92 | $97.53 |
| Resistance Level | $26.00 | $115.17 |
| Average True Range (ATR) | 1.19 | 3.64 |
| MACD | 0.09 | 2.46 |
| Stochastic Oscillator | 72.59 | 89.66 |
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
Owens-Corning Inc is a manufacturer of glass fiber utilized in composites and building materials. It has an integrated business model with four reportable segments: Composites, Insulation, Doors, and Roofing. It generates maximum revenue from the Roofing segment. Its Roofing segment laminate and strip asphalt roofing shingles, roofing components, synthetic packaging materials, and oxidized asphalt. It meets the growing demand for longer-lasting, aesthetically attractive laminate products with modest capital investment. Geographically the company generates the majority of its revenue from the United States.